749 results
Page 5 of 38
6-K
EX-99.1
lgd1u1j4
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
EX-99.1
7gdeycmn8k1ef m40d86
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
6-K
cvfyuviy84l w7
20 Jul 16
Current report (foreign)
12:00am
424B5
whwu gk1zfz5i
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
hjqeufhrm6zhn1qba
10 Jun 16
Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation
12:00am
6-K
EX-99.1
l2a4lc
18 Apr 16
First-HD Study shows improvements in Total Motor Score and Swallowing Function in Huntington disease patients treated with SD-809
12:00am
6-K
EX-99.1
g1hyuq 60o6b7
12 Apr 16
Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual Meeting
12:00am
6-K
z3mw23y8ga
30 Nov 15
Current report (foreign)
12:00am
424B5
ph4433qb3o8tbae2nsdw
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
rwca5 zwv
30 Nov 15
Current report (foreign)
12:00am
424B5
hw7 8wloot0
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
q3fvsaat 5by
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
n1vxho s77q8cmo
28 Sep 15
Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis
12:00am
6-K
EX-99.1
2uxr47agepyxl 5s
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am
6-K
EX-99.3
9bhytwd7nntlk
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.1
vti 0dt09bfnp4f
23 Mar 15
Live Filing
12:00am
6-K
EX-99.1
ap1 2vaee
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
9dgyqnoxbe 9pn
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
EX-99.1
3tgpenved
27 Feb 15
Live Filing
12:00am